113 related articles for article (PubMed ID: 9871709)
1. The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.
Miller TA; Vachaspati PR; Labroli MA; Thompson CD; Bulman AL; Macdonald TL
Bioorg Med Chem Lett; 1998 May; 8(9):1065-70. PubMed ID: 9871709
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
[TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.
Eymin B; Solary E; Chevillard S; Dubrez L; Goldwasser F; Duchamp O; Genne P; Leteurtre F; Pommier Y
Int J Cancer; 1995 Oct; 63(2):268-75. PubMed ID: 7591216
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins.
Gazit A; App H; McMahon G; Chen J; Levitzki A; Bohmer FD
J Med Chem; 1996 May; 39(11):2170-7. PubMed ID: 8667360
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases.
Sui Z; Altom J; Nguyen VN; Fernandez J; Bernstein JI; Hiliard JJ; Barrett JF; Podlogar BL; Ohemeng KA
Bioorg Med Chem; 1998 Jun; 6(6):735-42. PubMed ID: 9681139
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.
Solary E; Leteurtre F; Paull KD; Scudiero D; Hamel E; Pommier Y
Biochem Pharmacol; 1993 Jun; 45(12):2449-56. PubMed ID: 8392342
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity of indolopyrrolemaleimides.
Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.
Wu P; Su Y; Liu X; Zhang L; Ye Y; Xu J; Weng S; Li Y; Liu T; Huang S; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Nov; 46(11):5540-8. PubMed ID: 21945250
[TBL] [Abstract][Full Text] [Related]
9. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
Cline SD; Macdonald TL; Osheroff N
Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
[TBL] [Abstract][Full Text] [Related]
10. Azatoxin derivatives with potent and selective action on topoisomerase II.
Leteurtre F; Sackett DL; Madalengoitia J; Kohlhagen G; MacDonald T; Hamel E; Paull KD; Pommier Y
Biochem Pharmacol; 1995 May; 49(9):1283-90. PubMed ID: 7763310
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of 7H-benzo[4,5]indolo[2,3-b]-quinoxaline derivatives.
Shibinskaya MO; Karpenko AS; Lyakhov SA; Andronati SA; Zholobak NM; Spivak NY; Samochina NA; Shafran LM; Zubritsky MJ; Galat VF
Eur J Med Chem; 2011 Feb; 46(2):794-8. PubMed ID: 21172726
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agents. Part 186: Synthesis and biological evaluation of demethylcolchiceinamide analogues as cytotoxic DNA topoisomerase II inhibitors.
Guan J; Zhu XK; Tachibana Y; Bastow KF; Brossi A; Hamel E; Lee KH
Bioorg Med Chem; 1998 Nov; 6(11):2127-31. PubMed ID: 9881102
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.
Almandil NB; Taha M; Farooq RK; Alhibshi A; Ibrahim M; Anouar EH; Gollapalli M; Rahim F; Nawaz M; Shah SAA; Ahmed QU; Zakaria ZA
Molecules; 2019 Mar; 24(6):. PubMed ID: 30871147
[TBL] [Abstract][Full Text] [Related]
14. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency.
Chen P; Iwanowicz EJ; Norris D; Gu HH; Lin J; Moquin RV; Das J; Wityak J; Spergel SH; de Fex H; Pang S; Pitt S; Shen DR; Schieven GL; Barrish JC
Bioorg Med Chem Lett; 2002 Nov; 12(21):3153-6. PubMed ID: 12372522
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antifungal activities of novel 5,6-dihydro-indolo[1,2-a]quinoxaline derivatives.
Xu H; Fan LL
Eur J Med Chem; 2011 May; 46(5):1919-25. PubMed ID: 21388718
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.
You L; Cho EJ; Leavitt J; Ma LC; Montelione GT; Anslyn EV; Krug RM; Ellington A; Robertus JD
Bioorg Med Chem Lett; 2011 May; 21(10):3007-11. PubMed ID: 21478016
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight indole fragments as IMPDH inhibitors.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2535-8. PubMed ID: 16483769
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
